Itraconazole in leukemic patients with invasive aspergillosis (IA): Impact on intensive chemotherapy completion
- 1 September 1994
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 53 (3) , 183-185
- https://doi.org/10.1111/j.1600-0609.1994.tb00670.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Prophylactic Intravenous Amphotericin B in Neutropenic Autologous Bone Marrow Transplant RecipientsThe Journal of Infectious Diseases, 1992
- The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin BJournal of Infection, 1991
- Itraconazole therapy in aspergillosis: Study in 49 patientsJournal of the American Academy of Dermatology, 1990
- Prophylaxis of Fungal Infections with Itraconazole during Remission-Induction TherapyMycoses, 1989
- Treatment of invasive aspergillosis with itraconazoleThe American Journal of Medicine, 1989
- An approach to intensive antileukemia therapy in patients with previous invasive aspergillosisThe American Journal of Medicine, 1988
- Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapyThe American Journal of Medicine, 1988
- Prolonged Granulocytopenia: The Major Risk Factor for Invasive Pulmonary Aspergillosis in Patients with Acute LeukemiaAnnals of Internal Medicine, 1984